TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 16386168

Group type: EXPERIMENTAL
Intervention: Telephone intervention
Number of subjects: 85

Group type: COMPARATOR
Intervention: Minimal intervention (written information, goal-setting, and action plans)
Number of subjects: 85
Study: 12167115

Group type: EXPERIMENTAL
Intervention: Omeprazole (OMP) 20 mg once daily
Number of subjects: 56

Group type: COMPARATOR
Intervention: Famotidine (FAM) 20 mg twice daily
Number of subjects: 56
Study: 10559097

Group type: EXPERIMENTAL
Intervention: Continuous aspiration of subglottic secretions (CASS)
Number of subjects: 343

Group type: COMPARATOR
Intervention: Routine postoperative medical care without CASS
Number of subjects: 343
Study: 8913711

Group type: EXPERIMENTAL
Intervention: Ondansetron (O) 16 mg 3 times/day
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Ondansetron (O)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Placebo (P)
Number of subjects: 21
Study: 1905438

Group type: EXPERIMENTAL
Intervention: Dextrose 70% injection (D70W) plus 15% amino acids for PN, 25-mL piggybacks, selected drugs added to the PN solution
Number of subjects: 20

Group type: COMPARATOR
Intervention: D70W plus 10% amino acids, 50- or 100-mL piggybacks
Number of subjects: 20
Study: 6393976

Group type: EXPERIMENTAL
Intervention: 1000 mg ASA/d
Number of subjects: 867

Group type: EXPERIMENTAL
Intervention: 60 mg ASA/d
Number of subjects: 867

Group type: EXPERIMENTAL
Intervention: 30 mg ASA/d
Number of subjects: 867

Group type: COMPARATOR
Intervention: No ASA administration (control group)
Number of subjects: 867
Study: 30659044

Group type: EXPERIMENTAL
Intervention: Low-carbohydrate food-based diet providing around 800 kcal/day for 8 weeks followed by 4 weeks of weight maintenance
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Healthcare professionals conducting the intervention delivery session
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Participants attending the final follow-up session
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Change in haemoglobin A1c
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Change in weight
Number of subjects: 30
Study: 29204869

Group type: EXPERIMENTAL
Intervention: Valerate estradiol 2 mg daily + dihydrogesterone 10 mg daily during luteal phase for 3 months before IVF
Number of subjects: 26

Group type: COMPARATOR
Intervention: No pre-treatment
Number of subjects: 26
Study: 27528065

Group type: EXPERIMENTAL
Intervention: Gut microbiota composition assessment via 16S ribosomal RNA sequencing
Number of subjects: 205

Group type: EXPERIMENTAL
Intervention: Assessment of butyrate-producing genes via real-time polymerase chain reaction
Number of subjects: 205

Group type: EXPERIMENTAL
Intervention: Measurement of plasminogen activator inhibitor-1 levels in fasting serum
Number of subjects: 205

Group type: EXPERIMENTAL
Intervention: Assessment of butyrate production capacity
Number of subjects: 205

Group type: EXPERIMENTAL
Intervention: Correlation analysis of butyrate kinase expression and Odoribacter abundance
Number of subjects: 205
Study: 24038035

Group type: COMPARATOR
Intervention: Lopinavir/ritonavir (LPV/r)
Number of subjects: 116

Group type: COMPARATOR
Intervention: Efavirenz (EFV)
Number of subjects: 116
Study: 22841038

Group type: EXPERIMENTAL
Intervention: Portable monitoring device (Stardust - STD) used at home (STDHome)
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Portable monitoring device (Stardust - STD) used in sleep laboratory (PSG-STDLab)
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Portable monitoring device (Stardust - STD)
Number of subjects: 26
Study: 20719811

Group type: EXPERIMENTAL
Intervention: PCQ-infertility questionnaire
Number of subjects: 888

Group type: EXPERIMENTAL
Intervention: PCQ-infertility subscale 'communication'
Number of subjects: 888

Group type: EXPERIMENTAL
Intervention: PCQ-infertility subscale 'continuity'
Number of subjects: 888

Group type: EXPERIMENTAL
Intervention: PCQ-infertility importance item
Number of subjects: 888

Group type: COMPARATOR
Intervention: Comparison between clinics
Number of subjects: 888
Study: 18997657

Group type: EXPERIMENTAL
Intervention: Moderate Intensity (MI)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: High Intensity (HI)
Number of subjects: 20
Study: 15763055

Group type: EXPERIMENTAL
Intervention: Toubiao Qingfei Decoction (TBQFD) + Western medicines
Number of subjects: 46

Group type: COMPARATOR
Intervention: Western medicines
Number of subjects: 46
Study: 12394288

Group type: EXPERIMENTAL
Intervention: Amisulpride 50 mg/day
Number of subjects: 71

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 71
Study: 10442359

Group type: EXPERIMENTAL
Intervention: uracil/tegafur plus oral calcium folinate (UFT)
Number of subjects: 373

Group type: COMPARATOR
Intervention: 5‐fluorouracil (5‐FU) plus oral calcium folinate
Number of subjects: 373
Study: 8573687

Group type: EXPERIMENTAL
Intervention: 125 mg oral dose of terbinafine
Number of subjects: 16
Study: 2105087

Group type: EXPERIMENTAL
Intervention: Nifedipine (n = 25)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control (Nitroglycerin, n = 25)
Number of subjects: 50
Study: 30465

Group type: EXPERIMENTAL
Intervention: Lorazepam 2.5 mg
Number of subjects: 138

Group type: COMPARATOR
Intervention: Promethazine 50 mg
Number of subjects: 138
Study: 31376501

Group type: EXPERIMENTAL
Intervention: Parent-Child Interaction Therapy with Emotion Development module (PCIT-ED)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Standard Parent-Child Interaction Therapy (PCIT)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Wait List (WL) condition
Number of subjects: 0
Study: 30971158

Group type: EXPERIMENTAL
Intervention: Pulvertaft repair with three weaves
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Double Pulvertaft repair
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Locking Pulvertaft repair
Number of subjects: 45

Group type: COMPARATOR
Intervention: Traditional Pulvertaft weave
Number of subjects: 45
Study: 29191593

Group type: EXPERIMENTAL
Intervention: Ramucirumab plus docetaxel
Number of subjects: 360

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 360
Study: 25987078

Group type: EXPERIMENTAL
Intervention: Recombinant human endostatin (Endostar) 7.5 mg/m2, administered on postoperative day 89, 34 h/time, daily, for 14 weeks, total of 4 cycles
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Recombinant human endostatin (Endostar)
Number of subjects: 75

Group type: COMPARATOR
Intervention: Control group received postoperative complementary chemotherapy containing two-agent platinum protocol
Number of subjects: 75
Study: 23328488

Group type: EXPERIMENTAL
Intervention: Inguinal approach
Number of subjects: 120

Group type: COMPARATOR
Intervention: Subinguinal approach
Number of subjects: 120
Study: 21439754

Group type: EXPERIMENTAL
Intervention: CAC scanning
Number of subjects: 2137

Group type: COMPARATOR
Intervention: No CAC scanning
Number of subjects: 2137
Study: 19435759

Group type: EXPERIMENTAL
Intervention: Downton Index (IG)
Number of subjects: 1125

Group type: COMPARATOR
Intervention: No tool used (CG)
Number of subjects: 1125
Study: 16758412

Group type: EXPERIMENTAL
Intervention: PnCRM7
Number of subjects: 749

Group type: COMPARATOR
Intervention: Group C meningococcal conjugate vaccine
Number of subjects: 749
Study: 15234136

Group type: EXPERIMENTAL
Intervention: Topical ofloxacin applied 4 times a day for 3 days before surgery
Number of subjects: 75

Group type: COMPARATOR
Intervention: Topical ofloxacin applied 1 hour before surgery (control group)
Number of subjects: 75
Study: 11402115

Group type: EXPERIMENTAL
Intervention: L-dopa (300/75 mg/d)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Pramipexole (1.5 mg/d)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 9431265

Group type: EXPERIMENTAL
Intervention: Electrical Nerve Stimulation (ENS) therapy
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Electrical Muscle Stimulation (EMS) therapy
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo treatment (control group)
Number of subjects: 60
Study: 7818046

Group type: EXPERIMENTAL
Intervention: Radiant heater (group R, n = 11)
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Forced air system (group B, n = 12)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Normal cotton hospital blanket (group K, n = 12)
Number of subjects: 35
Study: 3045049

Group type: EXPERIMENTAL
Intervention: ceftizoxime
Number of subjects: 114

Group type: COMPARATOR
Intervention: cefotaxime
Number of subjects: 114
Study: 31127755

Group type: EXPERIMENTAL
Intervention: Platelet-rich plasma (PRP) treatment - 4-ml PRP intra-articularly (IA) in three doses at one-week intervals
Number of subjects: 60

Group type: COMPARATOR
Intervention: Saline solution - 4-ml saline solution IA (control group)
Number of subjects: 60
Study: 31334544

Group type: EXPERIMENTAL
Intervention: MCT group (6 g/d of medium-chain triglycerides)
Number of subjects: 64

Group type: COMPARATOR
Intervention: LD + MCT group (1.2 g l-leucine, 20 μg cholecalciferol, 6 g/d MCTs)
Number of subjects: 64

Group type: COMPARATOR
Intervention: LCT group (6 g/d of long-chain triglycerides)
Number of subjects: 64
Study: 30645864

Group type: EXPERIMENTAL
Intervention: Meat-containing canned food for enteral nutrition (240 ml, 2 portions daily for 14 days)
Number of subjects: 40
Study: 28644183

Group type: COMPARATOR
Intervention: Azathioprine (AZA)
Number of subjects: 767

Group type: EXPERIMENTAL
Intervention: Mercaptopurine (MP)
Number of subjects: 767
Study: 23475103

Group type: EXPERIMENTAL
Intervention: Dexamethasone (DEX) pre-treatment for 4 days prior to chemotherapy
Number of subjects: 56

Group type: COMPARATOR
Intervention: No Dexamethasone (no DEX)
Number of subjects: 56
Study: 21126771

Group type: EXPERIMENTAL
Intervention: Glaucoma
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Autosomal‐dominant optic atrophy (ADOA)
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Leber's hereditary optic neuropathy (LHON)
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Normal controls
Number of subjects: 23

Group type: COMPARATOR
Intervention: Pathologic but nonglaucomatous discs
Number of subjects: 23

Group type: COMPARATOR
Intervention: Normal discs
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Pallor assessment in glaucomatous discs
Number of subjects: 23
Study: 19595605

Group type: EXPERIMENTAL
Intervention: TachoSil
Number of subjects: 120

Group type: COMPARATOR
Intervention: Standard treatment (conventional haemostatic fleece)
Number of subjects: 120
Study: 17621464

Group type: EXPERIMENTAL
Intervention: Sequential pegylated interferon‐α2a plus delayed‐initiation tenofovir
Number of subjects: 0

Group type: COMPARATOR
Intervention: Dual nucleoside/nucleotide suppression
Number of subjects: 0
Study: 14685799

Group type: EXPERIMENTAL
Intervention: Bezafibrate
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Fenofibrate
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Gemfibrozil
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 11698879

Group type: EXPERIMENTAL
Intervention: Self-management booklet
Number of subjects: 311

Group type: EXPERIMENTAL
Intervention: Advice to take regular exercise
Number of subjects: 311

Group type: EXPERIMENTAL
Intervention: Both booklet and exercise advice
Number of subjects: 311

Group type: COMPARATOR
Intervention: Control group (neither intervention)
Number of subjects: 311
Study: 9446401

Group type: EXPERIMENTAL
Intervention: Kidney transplantation in patients with relative contraindications
Number of subjects: 51

Group type: COMPARATOR
Intervention: Control group of 413 patients without relative contraindications
Number of subjects: 51
Study: 7947854

Group type: EXPERIMENTAL
Intervention: Incentive group (received a Gerry 'Cuddler' for returning for examination within 12 weeks of delivery)
Number of subjects: 240

Group type: COMPARATOR
Intervention: Non-incentive group (no incentive offered)
Number of subjects: 240
Study: 2850807

Group type: EXPERIMENTAL
Intervention: Guar gum (15-30 g per day)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 23
Study: 31859172

Group type: EXPERIMENTAL
Intervention: Active Children Through Individual Vouchers Evaluation intervention (activity vouchers of £20 per month, peer mentoring scheme, support worker engagement for 12 months)
Number of subjects: 909

Group type: EXPERIMENTAL
Intervention: Active Children Through Individual Vouchers Evaluation intervention
Number of subjects: 909

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 909
Study: 29435911

Group type: EXPERIMENTAL
Intervention: Telephone-based intervention (16 calls over 3 months)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 100
Study: 27509050

Group type: EXPERIMENTAL
Intervention: LRM (n = 17): 3 sets of 4-6 RM
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: HRM (n = 16): 3 sets of 12-15 RM
Number of subjects: 45

Group type: COMPARATOR
Intervention: Control (CON, n = 12)
Number of subjects: 45
Study: 24150927

Group type: EXPERIMENTAL
Intervention: IV ceftaroline fosamil 1,500 mg with avibactam 2,000 mg
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: IV ceftazidime 3,000 mg with avibactam 2,000 mg
Number of subjects: 51

Group type: COMPARATOR
Intervention: Oral moxifloxacin 400 mg (open-label positive control)
Number of subjects: 51

Group type: COMPARATOR
Intervention: IV placebo (saline)
Number of subjects: 51
Study: 21920502

Group type: EXPERIMENTAL
Intervention: Acute tryptophan depletion (ATD)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 20811582

Group type: EXPERIMENTAL
Intervention: Opioid receptor antagonist naloxone
Number of subjects: 0
Study: 18267008

Group type: EXPERIMENTAL
Intervention: Negative pressure wound therapy (NPWT)
Number of subjects: 2755

Group type: COMPARATOR
Intervention: Conventional wound therapy
Number of subjects: 2755
Study: 16835758

Group type: EXPERIMENTAL
Intervention: Live attenuated Oka strain varicella vaccine (Varilrix, GlaxoSmithKline Biologicals)
Number of subjects: 160
Study: 12590879

Group type: EXPERIMENTAL
Intervention: Intra-articular injection of hyaluronans
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Hyaluronans
Number of subjects: 0
Study: 10773631

Group type: EXPERIMENTAL
Intervention: Fluoride varnish (FV, Fluor Protector) containing 0.1% F, treated every 3rd month for 3 years (12 treatments total)
Number of subjects: 180

Group type: COMPARATOR
Intervention: Chlorhexidine varnish (CV, Cervitec) containing 1% chlorhexidine and 1% thymol, treated every 3rd month for 3 years (12 treatments total)
Number of subjects: 180
Study: 8809428

Group type: EXPERIMENTAL
Intervention: Cetirizine 20 mg
Number of subjects: 26

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 26
Study: 8338403

Group type: EXPERIMENTAL
Intervention: DDD pacing
Number of subjects: 10

Group type: COMPARATOR
Intervention: VVI pacing
Number of subjects: 10
Study: 3436485

Group type: EXPERIMENTAL
Intervention: Iron protein succinylate (80 mg Fe3+)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Ferritin (80 mg Fe3+)
Number of subjects: 0
Study: 30045094

Group type: EXPERIMENTAL
Intervention: NAVA with 40% unloading
Number of subjects: 10

Group type: COMPARATOR
Intervention: Pressure support
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: NAVA with 60% unloading
Number of subjects: 10
Study: 26875428

Group type: EXPERIMENTAL
Intervention: Heart rate-guided beta-blocker titration
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Beta-blocker uptitration
Number of subjects: 100
Study: 24894577

Group type: EXPERIMENTAL
Intervention: High level of positive end-expiratory pressure (12 cm H2O) with recruitment manoeuvres
Number of subjects: 900

Group type: COMPARATOR
Intervention: Low level of positive end-expiratory pressure (≤2 cm H2O) without recruitment manoeuvres
Number of subjects: 900

Group type: EXPERIMENTAL
Intervention: Higher PEEP group
Number of subjects: 900

Group type: COMPARATOR
Intervention: Lower PEEP group
Number of subjects: 900
Study: 23541564

Group type: EXPERIMENTAL
Intervention: Paclitaxel plus everolimus (5mg p.o. daily, after a step-wise dose-escalation starting from 2.5mg bid) for 12 weeks before surgery
Number of subjects: 403

Group type: COMPARATOR
Intervention: Paclitaxel alone (80 mg/m(2) weekly for 12 weeks)
Number of subjects: 403

Group type: EXPERIMENTAL
Intervention: Paclitaxel plus everolimus
Number of subjects: 403

Group type: COMPARATOR
Intervention: Paclitaxel alone
Number of subjects: 403
Study: 20510986

Group type: EXPERIMENTAL
Intervention: STTotal‐11
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: STUp‐11
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: STTotal‐11 and STUp‐11
Number of subjects: 43
Study: 18091017

Group type: EXPERIMENTAL
Intervention: 6.4% carbohydrate-electrolyte (CHO-E) solution
Number of subjects: 6

Group type: COMPARATOR
Intervention: Placebo (PLA)
Number of subjects: 6
Study: 15915277

Group type: EXPERIMENTAL
Intervention: Support of a healthcare practitioner and a family member
Number of subjects: 0
Study: 12931800

Group type: EXPERIMENTAL
Intervention: Navigation system during total knee arthroplasty
Number of subjects: 240

Group type: COMPARATOR
Intervention: Hand-guided technique
Number of subjects: 240
Study: 11014761

Group type: EXPERIMENTAL
Intervention: Experimental conditions with varying parameters (seat height, pedal travel, pedal travel inclination, pedal resistance)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Pedal resistance and pedal travel
Number of subjects: 15
Study: 8970358

Group type: EXPERIMENTAL
Intervention: 2 ppm NO2 for 4 h
Number of subjects: 44
Study: 1461553

Group type: EXPERIMENTAL
Intervention: nimesulide (200 mg/day)
Number of subjects: 40

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 40
Study: 3984360

Group type: EXPERIMENTAL
Intervention: Educational intervention addressing urinary tract infections, its risk factors, and behavioral changes
Number of subjects: 34

Group type: COMPARATOR
Intervention: Routine patient information provided by practitioners
Number of subjects: 34
Study: 30096200

Group type: EXPERIMENTAL
Intervention: FSMS-RUTF
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: MSMS-RUTF
Number of subjects: 0

Group type: COMPARATOR
Intervention: PM-RUTF
Number of subjects: 0
Study: 27499311

Group type: EXPERIMENTAL
Intervention: Oral testosterone undecanoate (40 mg/day women, 160 mg/day men) and high energy oral nutritional supplement (2108-2416 kJ/day)
Number of subjects: 53

Group type: COMPARATOR
Intervention: Placebo medication and low energy (142-191 kJ/day) 'placebo' oral nutritional supplementation
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: Oral testosterone undecanoate and nutritional supplementation
Number of subjects: 53
Study: 24907147

Group type: EXPERIMENTAL
Intervention: ETN + MTX
Number of subjects: 723

Group type: COMPARATOR
Intervention: csDMARD + MTX
Number of subjects: 723
Study: 22434018

Group type: EXPERIMENTAL
Intervention: Hearing augmentation device
Number of subjects: 192

Group type: COMPARATOR
Intervention: Control group (no hearing augmentation)
Number of subjects: 192
Study: 20616774

Group type: EXPERIMENTAL
Intervention: Arginine-containing nutritional supplement (9 g per day until full PU healing)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Historical control group (no specific intervention mentioned)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Arginine supplementation for category 2 PU
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Arginine supplementation for category 3 PU
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Arginine supplementation for category 4 PU
Number of subjects: 18
Study: 18534138

Group type: EXPERIMENTAL
Intervention: Insulin-blood cardioplegia (insulin and glucose added)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Blood cardioplegia (control group)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Insulin-blood cardioplegia
Number of subjects: 24
Study: 16474301

Group type: EXPERIMENTAL
Intervention: Pentoxyphylline
Number of subjects: 0
Study: 12433835

Group type: EXPERIMENTAL
Intervention: HuEP5C7 (20 mg/kg IV)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study: 9949357

Group type: EXPERIMENTAL
Intervention: 0.4 ppm ozone
Number of subjects: 0

Group type: COMPARATOR
Intervention: Clean air
Number of subjects: 0
Study: 7585494

Group type: EXPERIMENTAL
Intervention: Foam brush soaked in chlorhexidine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Toothbrush
Number of subjects: 0

Group type: COMPARATOR
Intervention: Foam brush (not soaked in chlorhexidine)
Number of subjects: 0
Study: 2202920

Group type: EXPERIMENTAL
Intervention: Ciclosporin 100 ng/ml and prednisone (0.15 mg/kg/day)
Number of subjects: 94

Group type: EXPERIMENTAL
Intervention: Ciclosporin 50 ng/ml, prednisone (0.15 mg/kg/day), and azathioprine (1 mg/kg/day)
Number of subjects: 94

Group type: COMPARATOR
Intervention: Prednisone and azathioprine (control group)
Number of subjects: 94
Study: 6449783

Group type: EXPERIMENTAL
Intervention: IK-6 (combination of fenoterol and ipratropium bromide)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: IK-6
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: IK-6 (20 puffs)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Fenoterol (20 puffs)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Ipratropium bromide (20 puffs)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Oxitropium bromide (20 puffs)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Dibenzothiepine-derivative (20 puffs)
Number of subjects: 22
Study: 31434537

Group type: EXPERIMENTAL
Intervention: Lower-Extremity Intensive Functional Training (LIFT)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Hand-Arm Bimanual Intensive Therapy (H-HABIT)
Number of subjects: 24
Study: 28241715

Group type: EXPERIMENTAL
Intervention: Suture repair group (40 patients)
Number of subjects: 91

Group type: COMPARATOR
Intervention: Control group (33 patients)
Number of subjects: 91

Group type: EXPERIMENTAL
Intervention: Suture repair group
Number of subjects: 91

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 91
Study: 26163644

Group type: EXPERIMENTAL
Intervention: Arm I: Irradiation of the whole pelvis to a dose of 50 Gy in 27 fractions, weekly cisplatin 40 mg/m2, HDR-ICBT after one week of completion of EBRT (7 Gy to point A for three insertions at one week intervals)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Arm II: Irradiation of the whole pelvis to a dose of 50 Gy in 27 fractions, cisplatin 20 mg/m2/day from D1‐5 and D24‐28, HDR-ICBT after 40Gy (7 Gy to point A for three insertions on days 23, 30, 37)
Number of subjects: 50
Study: 24261438

Group type: EXPERIMENTAL
Intervention: Fixed-dose combination of paracetamol, chlorphenamine and phenylephrine (5 capsules per day for 48 to 72 hours)
Number of subjects: 146

Group type: COMPARATOR
Intervention: Placebo (5 capsules per day for 48 to 72 hours)
Number of subjects: 146